GORAN
B. KLINTMALM, M.D., PH.D., F.A.C.S.
LIST OF PUBLICATIONS
PEER
REVIEWED JOURNALS
1.
Tillegard A,
Klintmalm G,
2.
Klintmalm
G, Tillegard A,
and Magnusson G. Patienter som
kraver antiepileptika - en hogriskgrupp vid njurtransplantation. Svensk Kirurgi 36(2):61-62,
1978.
3.
Klintmalm
G, Berg B,
Lundgren G, Ljungdahl I, Magnusson G, Tillegard A, Groth CG, and Franksson C. 500
njurtransplantationer i Stockholm.
Svensk Kirurgi 37(1):130-133, 1979.
4.
Klintmalm
G, Astrom H,
Bergenwald L, Cronestrand R, von Euler C, and Juhlin-Dannfelt A. Blodflodet i a.
carotis interna vid varierande blodvolym och PCO2 under operation for
carotisstenos. Svensk
Kirurgi 37(1):138-139, 1979.
5.
Berg B, Groth
CG, Klintmalm G, Lundgren G, Ringden O, and Moller E: Betydelsen av HLA-A, -B och -Dr typning
for resultaten efter njurtransplantation i Stockholm. Svensk Kirurgi 37(2):139-142,
1979.
6.
Lundgren G,
Cronestrand R, Groth CG, Klintmalm G, and Ost L. Artarstenoser i transplanterade
njurar. Svensk Kirurgi
37(2):147-148, 1979.
7.
Berg B, Groth
CG, Klintmalm G, Lundgren G, and Moller E. The implications of HLA-DR match for the
outcome of cadaveric renal transplantation. Scand J Urol Nephrol (Suppl)
54:29-31, 1980.
8.
Starzl TE, Weil
III R, Iwatsuki S, Klintmalm G, Schroter GPJ, Koep LJ, Iwaki Y, Terasaki
PI, and Porter KA. The use of
cyclosporine A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet, July,
151:17-26, 1980.
9.
Dahlborn M,
Cronestrand R, Klintmalm G, and Sundelius S. Blood inflow and coagulation in vascular
catheters. Comparison of the effect
of polysaccharide solutions, saline and contrast medium. Acta Radiol Diagn 21 (Fasc.
6):715-720, 1980.
10.
Klintmalm
G, Iwatsuki S,
and Starzl TE. Nephrotoxicity of
cyclosporine A in liver and kidney transplant patients. Lancet 1(28 Feb):470-471,
1981.
11.
Starzl TE,
Iwatsuki S, Klintmalm G, Schroter GPJ, Weil III R, Koep LJ, and Porter
KA: Liver transplantation, 1980,
with particular reference to cyclosporine-A. Trans Proc 13, (1)
(March):281-285, 1981.
12.
Iwatsuki S,
13.
Klintmalm
G, Iwatsuki S,
14.
Starzl TE: Iwatsuki S, Klintmalm GBG, Porter
KA, and Fernandez-Bueno C. Human
organ transplantation under cyclosporine A and steroids.
15.
Starzl TE,
Klintmalm GBG, Iwatsuki S, and Fernandez-Bueno C. Past and future prospects of orthoptic
liver transplantation. Arch
Surg 116:1342-1343, October 1981.
16.
Klintmalm
GBG, Iwatsuki S,
and Starzl TE. Abstract: Nephrotoxicity of cyclosporine A in
liver and kidney transplant patients.
In: International Synopses,
Ed. R. Kessler,
17.
Starzl TE,
Klintmalm GBG, Iwatsuki S, and Weil III R. Late follow-up after thoracic duct
drainage in cadaveric renal transplantation. Surg Gynecol Obstet 153:377-382,
1981.
18.
Klintmalm
GBG, Iwatsuki S,
and Starzl TE: Cyclosporine A
hepatotoxicity in 66 renal allograft recipients.
19.
Klingensmith III
WC, Whitney WP, Spitzer VM, Klintmalm GBG, Koep LM, and Kuni CC. Effect
of complete biliary-tract obstruction on serial hepatobiliary imaging in an
experimental model: concise
communication. J Nucl Med
22:866-868, 1981.
20.
Starzl TE,
Klintmalm GBG, Weil III R, Porter KA, Iwatsuki S, Schroter GP,
Fernandez-Bueno C, and MacHugh N.
Cyclosporine A and steroid therapy in 66 cadaver kidney recipients. Surg Gynecol Obstet 153:486-494,
1981.
21.
Starzl TE,
Klintmalm GBG, Porter KA, Iwatsuki S, and Schroter GPJ. Liver transplantation with use of
cyclosporine A and prednisone.
New Engl J Med 305:266-269, 1981.
22.
Klintmalm
GBG, Starzl TE,
Groth CG, Iwatsuki S, Ringden O, Lundgren G, Magnusson G, and Collste H. Cyclosporine A, ett nytt
immunosuppressivum vid hjart-, lever och njurtransplantation. Svensk Kirurgi 19:225,
1981.
23.
Klintmalm
GBG, Klingensmith
III WC, Iwatsuki S, Schroter GPJ, and Starzl TE. 99mTc-DTPA and
131I-Hippuran findings in liver transplant recipients treated with
cyclosporine A. Radiology 142:199-202, January,
1982.
24.
Klintmalm
GBG, Starzl TE,
Iwatsuki S, and Hakala T.
Cyclosporine A and kidney transplantation: present status of a partially randomized
trial. Trans Proc,
14(1)(March):98-99, 1982.
25.
Ringden, O,
Collste H, Klintmalm G, Lundgren G, Magnusson G, Wilczek H, and Groth
CG. Cyclosporine A in high-risk
renal transplant recipients and in recipients with azathioprine
intolerance. Trans Proc, 14,
(1) (March):100-102, 1982.
26.
Klintmalm
G, Astrom H,
Bergenwald L, Cronestrand R, von Euler C, and Juhlin-Dannfelt A. Intra-operative
variations in carotid artery blood flow and cardiac output: the effects of changes in blood volume
and carbon dioxide during surgery under neurolept anesthesia. Acta Chir Scand 148:121-125,
1982.
27.
Starzl TE,
Klintmalm GBG, and Iwatsuki S.
The true one-handed tie.
Surg Gynecol Obstet 154(6):576, 1982.
28.
Ringden O,
Persson U, Johansson G, Gahrton G, Groth CG, Klintmalm G, Lundgren G,
Lonnqvist B, and Moller E.
Correlation between increase in serum-IgE levels and clinical signs of
acute graft-versus-host disease.
Experimental Hematology Vol. 10, Suppl 10:94-95,
1982.
29.
Groth CG,
Collste H, Lundgren G, Wilczek H, Klintmalm G, Ringden O, Gunnarsson R,
and Ostman J. Successful outcome of segmental human
pancreatic transplantation with enteric exocrine diversion after modifications
in technique. Lancet
2:522-524, 1982.
30.
Groth CG, Berg
B, Collste H, Fehrman I, Klintmalm G, Lundgren G, Magnusson G, Ringden O,
Wilczek H, and Ost L.
Njurtransplantation.
In:
31.
Klintmalm
G. Hjart-och levertransplantation. In:
32.
Iwatsuki S,
Klintmalm GBG, and Starzl TE.
Total hepatectomy and liver replacement (orthotopic liver
transplantation) for primary hepatic malignancy. World J Surg 6:
1982.
33.
Klintmalm
G. Cyclosporine A (Sandimmune®)
- ett nytt immunosuppressivum.
Forskning och Praktik 7:97-101, 1982.
34.
Klintmalm
G, Bergstrand A,
Ringden O, Wasserman J, Collste H, Lundgren G, Wilczek, and Groth CG. Graft biopsy for the differentiation
between nephrotoxicity and rejection in cyclosporine-A-treated renal transplant
recipients. Trans Proc 15(1)
(March): 493-496, 1983.
35.
Ringden O, Ost
L, Klintmalm G, Tillegard A, Fehrman I, Wilczek H, Groth CG: Improved outcome in renal transplant
recipients above 55 years of age treated with cyclosporine and low doses of
steroids. Trans Proc 15(4)
(Suppl 1) (December): 1983.
36.
Klintmalm
G, Ringden O, and
Groth CG: Clinical and laboratory
signs in nephrotoxicity and rejection in cyclosporine-treated renal allograft
recipients. Trans Proc 15(4)
(Suppl 1 December):2815-2820, 1983.
37.
Klintmalm
GB and Husberg
BS: Etablering av ett
levertransplantationscentrum i
38.
Starzl TE,
Rosenthal JT, Hakala TR, Iwatsuki S, Shaw JB, and Klintmalm GB: Steps in immunosuppression for renal
transplantation. Kidney
International 23(Suppl. 14),S-60 1983.
39.
Ringden O, Baryd
I, Johansson B, Bolme P, Gahrton G, Groth CG, Klintmalm G, Lundgren G,
and Lonnqvist B: Increased
mortality in bone marrow transplant recipients accidentally receiving an
increased dose rate of total body irradiation. Experimental Hematology
11:131-133, 1983.
40.
Klintmalm
G: Cyclosporin A. Njurfunk 2:14-15,
1983.
41.
Gunnarsson R,
Klintmalm G, Lundgren G, Wilczek H, Ostman J, and Groth CG: Deterioration in glucose metabolism in
pancreatic transplant recipients given cyclosporine. Lancet 2:571-572,
1983.
42.
Klintmalm G
and Groth CG: Levertransplantation - utvecklingen gar
framat. Lakartidningen,
80(NR 42):3901, 1983.
43.
Klintmalm
G: Cyklosporin - immunhammare med vidgad
anvandning. Lakartidningen,
80(9 NR 47):4530-4531, 1983.
44.
Klintmalm
G and Lundgren
G: Can pre-transplant blood
transfusions and DR-matching be omitted in cyclosporine-A treated renal
transplant patients?
Scandinatransplant Report:24-26, 1983.
45.
Klintmalm
GBG, Cronestrand R,
Wennmalm A, Lundgren G, Groth CG:
Human Renal Allograft Blood Flow, Oxygen Extraction, and Prostaglandin
Release: Their Bearing on Graft
Function. Surgery
95(4)(April):427-432, 1984.
46.
Gunnarsson R,
Klintmalm G, Lundgren G, Tyden G, Wilczek H, Ostman J, and Groth CG.
Deterioration in glucose metabolism in pancreatic transplant recipients after
conversion from azathioprine to cyclosporine. Trans Proc 16(3) (June):709-712,
1984.
47.
Groth CG,
Lundgren G, Wilczek H, Klintmalm G, Tyden G, Gunnarsson R, and Ostman J.
Segmental pancreatic transplantation with duct ligature or enteric
diversion: technical aspects. Trans Proc, 16(3) (June):724-728,
1984.
48.
Lundgren G,
Wilczek H, Klintmalm G, Tyden G, and Groth CG: Procurement and preservation of human
pancreatic grafts. Trans
Proc 16(3) (June):681-683, 1984.
49.
Klintmalm
G, Althoff P,
Appleby G, and Segerbrandt E: Renal
function in a newborn baby delivered of a renal transplant patient taking
cyclosporine.
50.
Klintmalm
G, Sawe J, von
Bahr C, Ringden O, Lundgren G, Wilczek H, Tyden G, and Groth CG: Optimal cyclosporine plasma levels
decline with time of therapy.
Transplant Proc, 16(5) (October):1208-1211,
1984.
51.
Tyden G,
Lundgren G, Wilczek H, Klintmalm G, Ost L, Gunnarsson R, Ostman J,
and Groth CG: Recent experience
with pancreatic transplantation at huddinge hospital. Trans Proc 16(5)
(October):1270-1273, 1984.
52.
Svenson K,
Holmdahl R, Klareskog L, Wibell L, Sjoberg O, Klintmalm G, and Bostrom
H: Cyclosporine A (CyA) treatment
in a case of relapsing polychondritis.
Scand J Reumatol, 1984.
53.
Klintmalm
G: The first international congress on
cyclosporine - en rapport fran
54.
Groth CG, Tyden
G, Lundgren G, Wilczek H, Klintmalm G, Ost L, Gunnarsson R, and Ostman
J: Segmental pancreatic
transplantation with enteric exocrine diversion. World J Surg 8:257-261,
1984.
55.
Klintmalm
G and Sawe
J: High dose methylprednisolone
increases plasma cyclosporine levels in renal transplant recipients. Lancet 1:731,
1984.
56.
Ringden O,
Myrenfors P, Klintmalm G, Tyden G, and Ost L: Nephrotoxicity by co-trimoxazole and
cyclosporine in transplanted patients.
Lancet 1:1016-1017, 1984.
57.
Klintmalm
G, Bowman S,
Sundelin B, and Wilczek H:
Morphological changes in renal allografts after 12-46 months of
cyclosporine therapy: beneficial
effect of lower doses early after transplantation. Lancet 2:950-954,
1984.
58.
Klintmalm
G: Monitoring of cyclosporine/sandimmune
levels and the use of renal biopsies in the care of renal transplanted
patients. Excerpta Medica,
59.
Bohman S,
Klintmalm G, Ringden O, Sundelin B, and Wilczek H: Interstitial fibrosis in human kidney
grafts after 12 to 46 months of cyclosporine therapy. Trans Proc, 17(1)
(February):1168-1171, 1985.
60.
Klintmalm
G, Brynger H,
Flatmark A, Frodin L, Husberg B, Thorsby E, and Groth CG: The blood transfusion, DR matching, and
mixed lymphocyte culture effects are not seen in cyclosporine-treated renal
transplant recipients. Trans
Proc 17(1) (February):1026-1031, 1985.
61.
Iwatsuki S,
Esquivel CO, Klintmalm GBG,
62.
Klintmalm G,
Lonnqvist B, Oberg B, Gahrton G, Lernestedt J, Lundgren G, Ringden O, Robert K,
Wahren B, and Groth CG: Intravenous
foscarnet for the treatment of severe cytomegalovirus infection in allograft
recipients. Scand J Infect
Dis 17:157-163, 1985.
63.
Klintmalm
G, Sawe J,
Ringden O, and von Bahr C:
Cyclosporine plasma levels in renal transplant patients - association
with renal toxicity and allograft rejection.
64.
Ost L,
Klintmalm G, and Ringden O:
Mutual interaction between prednisolone and cyclosporine in renal
transplant patients. Trans
Proc 17:1252-1255, 1985.
65.
Klintmalm
G and Moore
AE: Organization of a new liver
transplant center. Seminars on
Liver Disease 5(4):412-417, 1985.
66.
Lundgren G,
Albrechtsen D, Flatmark A, Gabel H, Klintmalm G, Persson H, Groth CG,
Brynger H, Frodin L, Husberg B, Maurer W, and Thorsby E: HLA-matching and pretransplant blood
transfusions in cadaveric renal transplantation--a changing picture with
cyclosporine. Lancet July
12:66-69, 1986.
67.
Lundgren G,
Albrechtsen D, Brynger H, Flatmark A, Frodin L, Gabel H, Husberg B, Klintmalm
G, Maurer W, Persson H, Thorsby E, and Groth CG: Role of blood transfusions and HLA
matching in cyclosporine-treated renal transplant recipients: a scandinavian multicenter study. Trans Proc 18(5)
(October):1248-1255, 1986.
68.
Friskopp J and
Klintmalm G: Gingival
enlargement. A comparison between
cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 10:85-92,
1986.
69.
Ringden O,
Lonnqvist B, Paulin T, Ahlmen J, Klintmalm G, Wahren B, and Lernestedt
JO: Pharmacokinetics, safety and preliminary clinical experiences using
foscarnet in the treatment of cytomegalovirus infections in bone marrow and
renal transplant recipients.
Journal of Antimicrobial Chemotherapy 17:373-387,
1986.
70.
Klintmalm
GBG: Renal toxicity of cyclosporin, clinical
studies. Contr Nephrol, 51:
1986.
71.
Iwatsuki S,
Starzl TE, van Thiel D, Gordon RD, Esquivel CO, Tzakis A, Klintmalm G,
and Schade R: Liver transplantation
for primary sclerosing cholangitis.
Am. Assoc. for Study of Liver Diseases,
1986.
72.
Starzl TE,
Tzakis A, Makowka L, Fung J, Klintmalm G, Todo S, Gordon R, and Griffin
M: Combined liver and kidney
transplantation: with particular
reference to positive cytotoxic crossmatches. Kidney International, 31(1)
(January):218, 1987.
73.
Paulsen AW,
Valek TR, Blessing WS, Johnson DD, Parks RI, Pyron JT, Ramsay M, Simpson BR,
Swygert T, Walling P, and Klintmalm G: Hemodynamics during liver
transplantation with veno-venous bypass.
Trans Proc, 19(1) (February):2417, 1987.
74.
Bryan CF, Newman
JT, Nery J, Husberg B, Klintmalm GB, and Stone MJ: Quantitative and functional profile of
the immune system after liver transplantation. Trans Proc, (October):4340-4344,
1987.
75.
Klintmalm
G: Development of chronic renal
cyclosporine-A toxicity.
Nephrologie, 8:131-133, 1987.
76.
77.
Olson LM, Roden
J, Nery J, Husberg B, and Klintmalm G: Liver transplantation at baylor
university medical center: the
first eighteen months.
Lakartidningen 84(16):1351, 1987.
78.
Detre KM and LTD
Investigators: The NIDDK liver
transplantation database. Clin
Trans, 6:33-42, 1987.
79.
Roden J,
Klintmalm GB, Husberg BS, Nery J, and Olson LM: Cerebrospinal fluid inflammation during
OKT3 therapy. Lancet: 272,
1987.
80.
Fung J, Makowka
L, Tzakis A, Klintmalm G, Duquesnoy R, Gordon R, Todo S, Griffin M, and
Starzl T: Combined liver-kidney
transplantation: analysis of
patients with preformed lymphocytotoxic antibodies. Trans Proc 20(1) (Suppl 1)
(February): 1988.
81.
Iwatsuki S,
Starzl TE, Todo S, Gordon RD, Esquivel CO, Tzakis AG, Makowka L, Marsh JW,
Koneru B, Stieber A, Klintmalm G, and Husberg G: Experience in 1,000 liver transplants
under cyclosporine-steroid therapy:
a survival report. Trans
Proc 20(1) (Suppl 1) (February):498-504, 1988.
82.
Goldstein RM,
Olson LM, Klintmalm GBG, Husberg BS, Nery JR, Gonwa TA, Roden JS, and
83.
Gonwa TA,
Klintmalm GB, Husberg BS, Olson L, Nery J, and Roden J: Liver transplantation in patients with
preexisting acute and chronic renal failure. Trans Proc 20(1) (Suppl 1)
(February):561-563, 1988.
84.
Klintmalm
GB, Olson LM, Nery
JR, Husberg BS, and
85.
Klintmalm
GBG, Olson LM,
Paulsen AW, Whitten CW, and Husberg BS:
Hepatic arterial thrombosis after liver transplantation: intraoperative electromagnetic blood
flow evaluation. Trans Proc
20(1) (Suppl 1) (February):616-618, 1988.
86.
Greene CL,
Fehrman I, Tillery GW, Husberg BS, and Klintmalm GB: Transplant aspiration cytology detects
entities other than acute cellular rejection in liver allografts. Trans Proc 20(1) (Suppl 1)
(February):692-694, 1988.
87.
Olson LM,
Klintmalm GB, Husberg BS, Nery JR, Whitten CW, Paulsen AW, and McClure
R: Superoxide dismutase improves
organ preservation in liver transplantation. Trans Proc 20(1) (Suppl 1)
(February):961-964, 1988.
88.
Nery J,
Klintmalm G, Olson L, Neely S, Rippert L, Gonwa T, and Husberg B: Incidence and outcome of acute rejection
in liver transplantation. Trans
Proc 20(3) (Suppl) (June):375-377, 1988.
89.
Gonwa TA,
90.
Wilczek H,
Bohman SO, Klintmalm G, and Groth CG: Five years serial renal graft biopsy
study in cyclosporine-treated patients.
Trans Proc, 20(3) (Suppl 3) (June): 812-815,
1988.
91.
Markus BH,
Duquesnoy RJ,
92.
Klintmalm
GBG: The liver donor: special considerations. Trans Proc 20(5) (Suppl
7)(October): 9-11, 1988.
93.
Iwatsuki S,
Starzl TE, Todo S, Gordon R, Tzakis A, Marsh JW, Makowka L, Koneru B, Stieber A,
Klintmalm G, Husberg BS, and Van Thiel D: Liver transplantation in the treatment
of bleeding esophageal varices.
Surgery 104(4) October):697-705, 1988.
94.
Gonwa TA, Nery
JR, Husberg BS, and Klintmalm GB:
Simultaneous liver and renal transplantation in man.
95.
Paulsen AW,
Whitten CW, Ramsay MAE, Swygert T, and Klintmalm G: Patients presenting for hepatic
transplantation: comparison of
typical and low cardiac index groups.
Anesth Analg 67:S1- S266, 1988.
96.
Lindholm A,
Pousette A, Carlstrom K, and Klintmalm G: Cyclosporine-associated hypertrichosis
is not related to sex hormone levels following renal transplantation. Nephro 50:199-204,
1988.
97.
Makowka L, Sher
L, Kahn D, Tzakis AG, Todo S. Marsh JW, Stieber A, Koneru B, Klintmalm
GBG, Staschak SM, Iwatsuki S,
98.
Klintmalm
GBG and Nery
JR: Prevention, diagnosis, and
treatment of rejection in the adult hepatic transplant patient. Clin Trans 25-227,
1988.
99.
Poplawski S,
Gonwa TA, Greene C, Husberg BS, and Klintmalm G: Interstitial nephritis secondary to OKT3
administration. Clin Trans
2:341-343, 1988.
100.
Marino IR, Todo
S, Tzakis AG, Klintmalm G, Kelleher M, Iwatsuki S, Starzl TE, and
Esquivel CO: Treatment of hepatic
epithelioid hemangioendothelioma with liver transplantation. Cancer 62(10):2079-2084,
1988.
101.
Brajtbord D,
Parks RI, Ramsay MA, Paulsen AW, Valek TR, Swygert TH, and Klintmalm
GB: management of acute
elevation of intracranial pressure during hepatic transplantation. Anesthesiology 70(1):139-141,
1989.
102.
Mai M, Nery J,
Sutker W, Husberg B, Klintmalm G, and Gonwa T: DHPG (Gancyclovir) improves survival in
CMV pneumonia. Trans Proc
21(1)(February):2263-2265, 1989.
103.
Nikaein A,
Klintmalm G, Husberg B, and Stone MJ: Limiting dilution analysis: a new approach to identify the status of
allograft recipients. Trans
Proc 21(1) (February):2286-2289, 1989.
104.
Zachariah NY,
Nikaein A, Gonwa T, Alivizatos P, Klintmalm G, and Husberg B: Neoptrin: a biochemical marker in the
process of organ transplantation.
Trans Proc 21(1) (February):2294-2296, 1989.
105.
Poplawski S,
Gonwa T, Goldstein R, Husberg B, and Klintmalm G: Long term nephrotoxicity in liver
transplantation. Trans Proc
21(1)(February):2469-2471, 1989.
106.
Gonwa TA,
Poplawski S, Paulsen W, Brajtbord D, Goldstein R, Husberg B, and Klintmalm
G: Pathogenesis and outcome of
hepatorenal syndrome in patients undergoing orthotopic liver transplant.
107.
Gilbert SC,
Klintmalm G, Menter A, and Silverman A: Methotrexate-induced cirrhosis requiring
liver transplantation in three patients with psoriasis: a word of caution in light of the
expanding use of this "steroid-sparing" agent. JAMA (March)
1989.
108.
Markus BH,
Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GBG, Wiesner
RH, Van Thiel DH, and Starzl TE:
Efficacy of liver transplantation in patients with primary biliary
cirrhosis. New Eng J Med
320(26) (June 29):1709-1713, 1989.
109.
Stone MJ,
Klintmalm G, Polter D, Husberg B, and Egorin MJ: Neoadjuvant chemotherapy and orthotopic
liver transplantation for hepatocellular carcinoma.
110.
Gilbert SC,
Emmett M, Menter A, Silverman A, and Klintmalm G: Cyclosporine therapy for psoriasis: serum creatinine measurements are an
unreliable predictor of decreased renal function. Journal of the Am Academy of Derm
21(3) (Pt. 1):470-474, 1989.
111.
Klintmalm
GBG, Nery JR,
Husberg BS, Gonwa TA, and Tillery GW:
Rejection in liver transplantation.
Hepatology 10(6):978-985, 1989.
112.
113.
Takaoka F, Brown
MR, Paulsen W, Ramsay MAE, and Klintmalm GB: Adult respiratory distress syndrome
following orthotopic liver transplantation. Clin Trans 3:294-299,
1989.
114.
Sayage LH, Gonwa
TA, Goldstein RM, Husberg BS, and Klintmalm GB: Cytomegalovirus infection in orthotopic
liver transplantation. Trans
Int 2:96-101, 1989.
115.
Sayage LH,
Husberg BS, Klintmalm GB, Goldstein RM, and Gonwa TA: Vascular complications in adult liver
transplant patients. Value of
post-operative doppler ultrasound ccreening and the surgical management of
hepatic arterial thrombosis.
Clin Trans 3:344-348, 1989.
116.
Paulsen AW,
Whitten CW, Ramsay MAE, and Klintmalm GB: Considerations for anesthetic management
during veno-venous bypass in adult hepatic transplantation. Anesth Analg 68:489-496,
1989.
117.
Osther K and
Klintmalm G: The quick
western blot, a novel transportable 50-minute HIV-1 antibody test.
118.
Klintmalm
GB, Alivizatos PA,
Husberg BS, Howard TK, Small AB, Goldstein RM, and Cofer JM: Hepatic transplantation in a patient
with mesoatrial shunt and occlusion of the inferior vena cava. Surgery 107(2):220-223,
1990.
119.
Gilbert
SC, Klintmalm G, Menter A, and Silverman A. Methotrexate-induced
cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the
expanding use of this ‘steroid-sparing’ agent. Arch Intern Med 150(4): 889-91,
1990.
120.
Klintmalm
GB and Stone
MJ: Liver transplantation for
malignancy.
121.
Mora NP,
Klintmalm GB, Cofer JB, Poplawski SS, Goldstein RM, Gonwa TA, and Husberg
BS: Results after liver
retransplantation (RETx): a
comparative study between "elective" vs "nonelective" RETx. Trans Proc 22(4)
(August):1509-1511, 1990.
122.
Goldstein RM,
Secrest CL, Klintmalm GB, and Husberg BS: Problematic vascular reconstruction in
liver transplantation. Part I. Arterial. Surgery 107(5):540-543,
1990.
123.
Kirsch JP,
Howard TK, Klintmalm GB, Husberg BS, and Goldstein RM: Problematic vascular reconstruction in
liver transplantation. Part
II. Portovenous conduits. Surgery 107(5):544-548,
1990.
124.
Howard TK,
Klintmalm GBG, Cofer JB, Husberg BS, Goldstein RM, and Gonwa TA: The influence of preservation injury on
rejection in the hepatic transplant recipient.
125.
Takaoka F, Brown
MR, Ramsay MAE, Paulsen AW, Brajtbord D, and Klintmalm GB: Intraoperative
evaluation of eurocollins and university of wisconsin preservation solutions in
patients undergoing hepatic transplantation.
126.
Sayage L, Gunby
R, Gonwa T, Husberg B, Goldstein R, and Klintmalm G: Cytomegalovirus endometritis after liver
transplantation.
127.
Senzer NN, Stone
MJ, Klintmalm GB, and Polter D:
Adjuvant radiochemotherapy following orthotopic liver transplantation for
bile duct cancer.
128.
Cofer JB,
Klintmalm GB, Howard TK, Morris CV, Husberg BS, Goldstein RM, and Gonwa
TA: A comparison of UW with
eurocollins preservation solution in liver transplantation.
129.
Cofer JB, Morris
CA, Sutker WL, Husberg BS, Goldstein RM, Gonwa TA, and Klintmalm GB: A randomized double-blind study of the
effect of prophylactic immune globulin on the incidence and severity of CMV
infection in the liver transplant recipient. Trans Proc 23(1)
(February):1525-1527, 1991.
130.
Mora NP, Cofer
JB, Solomon H, Goldstein RM, Gonwa TA, Husberg BS, and Klintmalm GB: Analysis of severe infections (INF)
after 180 consecutive liver transplants:
the impact of amphotericin B prophylaxis for reducing the incidence and
severity of fungal infections.
Trans Proc 23(1) (February):1528-1530, 1991.
131.
Husberg BS,
Goldstein RM, Klintmalm GB, Gonwa T, Ramsay M, Cofer J, Solomon H, and
Watemberg I: A totally failing
liver may be more harmful than no liver at all: three cases of total hepatic
devascularization in preparation for emergency liver transplantation. Trans Proc 23(1)
(February):1533-1535, 1991.
132.
Gunning TC,
Brown MR, Swygert TH, Goldstein R, Husberg BS, Klintmalm GB, DiBona G,
Paulsen AW, Ramsay MAE, and Gonwa TA:
Perioperative renal function in patients undergoing orthotopic liver
transplantation.
133.
Gonwa TA, Morris
CA, Goldstein RM, Husberg BS, and Klintmalm GB: Long-term survival and renal function
following liver transplantation in patients with and without hepatorenal
syndrome--experience in 300 patients.
134.
Cofer JB, Morris
CA, Sutker WL. Husberg BS, Goldstein RM, Gonwa TA, and Klintmalm GB:
Immunotherapy with intravenous immunoglobulins. "the effect of prophylactic immune
globulin on cytomegalovirus infection in liver transplants." 229-235, Academic Press Ltd.,
1991.
135.
Gonwa TA, Morris
CA, Mai ML, Husberg BS, Goldstein RG, and Klintmalm GB: Race and liver transplantation. Arch Surg 126:1141-1143,
1991.
136.
Mora NP,
Klintmalm GB, Cofer JB, Solomon H, Goldstein RM, Gonwa TA, and Husberg
BS. Results after liver
transplantation in a group of 50 regrafted patients: two different concepts of elective
versus emergency retransplantation.
Trans Int 1991.
137.
Klintmalm
GB: Rejection therapies. Digestive Diseases and Sciences
36(10)(October):1431-1433, 1991.
138.
McDiarmid SV,
Klintmalm G, and Busuttil RW:
FK506 rescue therapy in liver transplantation: outcome and complications. Trans Proc 23(6)(December):2996,
1991.
139.
Demetris AJ,
Belle S, Hart J, Lewin K, Ludwig J, Snover D, Tillery GW, and Detre K. The liver transplantation database (LTD)
investigators: intraobserver and
interobserver variation in the histopathological assessment of liver allograft
rejection. Hepatology
1991.
140.
Gonwa TA,
Husberg B, Klintmalm GB, Goldstein RM, Capehart JE, Miller AH,
141.
Mor E,
Klintmalm GB, Gonwa TA, Solomon H, Holman MJ, Gibbs JF, Watemberg I,
Goldstein RM, and Husberg, BS: Use
of marginal donors for liver transplantation: A retrospective study of 365 liver
donors.
142.
Mor E, Solomon
H, Gibbs J, Holman M, Goldstein R, Husberg B, Gonwa T, and G
Klintmalm: Acute cellular
rejection following liver transplantation:
clinical pathologic features and effect on outcome. Sem in Liv Dis 12(1)
(February):28-40, 1992.
143.
Gibbs J, Holman
M, Diamond N, Goldstein R, Husberg B, and Klintmalm G: The evolving management of complicated
biliary strictures. Trans
Science 2(1)(March):7-11, 1992.
144.
Collins R,
Cooper B, Nikaein A, Klintmalm G, and Fay J: Graft-versus-host disease in a liver
transplant recipient. Ann of Int
Med 116:391-392, 1992.
145.
Cofer J,
Klintmalm G, Morris C, Solomon H, Watemberg I, Husberg B, and Jennings L:
A prospective randomized trial between eurocollins and
146.
Howard T,
Klintmalm G, Stone M, Cofer J, Husberg B, Goldstein R, and Gonwa T: Lymphoproliferative disorder
masquerading as rejection in liver transplant recipients -- an early aggressive
tumor with atypical presentation.
147.
Shaked A,
Goldstein R, Klintmalm G, Drazan K, Husberg B, and Busuttil R: Portosystemic shunt versus orthotopic
liver transplantation for the budd-chiari syndrome. Surg Gyn & Obs
174(6):453-459, 1992.
148.
Paulsen AW and
Klintmalm GB: Measurement of
human hepatic blood flow during transplant. Hepatology, 16(1):100-111,
1992.
149.
Klintmalm
GB: De Novo lymphoma after liver
transplantation. Clin Trans
6(3)(Part)(June): 272-274, 1992.
150.
Mora N, Gonwa T,
Goldstein R, Husberg B, and Klintmalm G: Risk of postoperative infection after
liver transplantation: a univariate
and stepwise logistic regression analysis of risk factors in 150 consecutive
patients. Clin Trans 46:
443-449, 1992.
151.
Mor E, Gonwa T,
Husberg B, Goldstein R, and Klintmalm G: Late-onset acute rejection in orthotopic
liver transplantation - associated risk factors and outcome.
152.
Sollinger H,
Belzer F, Deierhoi M, Diethelm A, Gonwa T, Kauffman R, Klintmalm G,
McDiarmid S, Roberts J, Rosenthal J, and Tomlanovich S: RS-61443 (mycophenolate mofetil): a multicenter study for refractory
kidney transplant rejection.
Annals of Surgery 216(4):513-519, 1992.
153.
Stone M,
Klintmalm G, Polter D, Husberg B, Mennel R, Ramsay M, Flemens E, and
Goldstein R: Neoadjuvant
chemotherapy and liver transplantion for hepatocellular carcinoma: a pilot study in 20 patients.
154.
Abouljoud M,
Mulligan D, and Klintmalm GB. Baylor
update: outcome analysis in liver transplantation. Clin Transpl: 161-73,
1993.
155.
Collins RH Jr,
Anastasi J, Terstappen LW, Nikaein A, Feng J, Fay JW, Klintmalm G, and Stone MJ. Brief
report: donor-derived long-term multilineage hematopoiesis in a liver-transplant
recipient. N Engl J Med 28(11):
762-5, 1993.
156.
Solomon H, Gonwa
T, Mor E, Holman M, Gibbs J, Watemberg I, Netto G, Goldstein R, Husberg B, and
Klintmalm G: OKT3 rescue for
steroid-resistant rejection in adult liver transplantation.
157.
Holman M, Gonwa
T, Cooper B, Husberg B, Goldstein R, Gibbs J, and Klintmalm G: FK506-associated thrombotic
thrombocytopenic purpura.
158.
Klintmalm
G, Goldstein R,
Gonwa T, Wiesner R, Krom R, Shaw B, Stratta R, Ascher N, Roberts J, Lake J,
Busuttil R, McDiarmid S, Esquivel C, Nakazato P, Marsh J, Woodie E, Kalayoglu M,
D'Alessandro A, Pirsch J, Miller C, Schwartz M, Lewis W, Monaco A, Jenkins R,
Emond J, Thistlethwaite J, Whitington P, Steinmuller D, Fitzsimmons W, and
Lawrence I: The use of prograf
(FK506) as rescue therapy for refractory rejection after liver
transplantation. Trans Proc
25(1):679-688, 1993.
159.
Klintmalm
G, Goldstein R,
Gonwa T, Wiesner R, Krom R, Shaw B, Stratta R, Ascher N, Roberts J, Lake J,
Busuttil R, McDiarmid S, Esquivel C, Nakazato P, Marsh J, Woodie E, Kalayoglu,
D'Alessandro A, Pirsch J, Miller C, Schwartz M, Lewis W, Monaco A, Jenkins R,
Emond J, Thistlethwaite J, Whitington P, Steinmuller D, Fitzsimmons W, and
Lawrence I: Use of FK506 for the
prevention of recurrent allograft rejection after successful conversion from
cyclosporine for refractory rejection.
Trans Proc 25(1):635-637, 1993.
160.
Klintmalm
G, Goldstein R,
Gonwa T, Wiesner R, Krom R, Shaw B, Stratta R, Ascher N, Roberts J, Lake J,
Busuttil R, McDiarmid S, Esquivel C, Nakazato P, Marsh J, Woodie E, Kalayoglu,
D'Alessandro A, Pirsch J, Miller C, Schwartz M, Lewis W, Monaco A, Jenkins R,
Emond J, Thistlethwaite J, Whitington P, Steinmuller D, Fitzsimmons W, and
Lawrence I: Prognostic factors for
successful conversion from cyclosporine to FK506-based immunosuppressive therapy
for refractory rejection after liver transplantation. Trans Proc
25(1):641-643, 1993.
161.
Levy M, Backman
L, Husberg B, Goldstein R, McMillan R, Gibbs J, Gonwa T, Holman M, and
Klintmalm G: De Novo
malignancy following liver transplantation: a single-center study. Trans Proc 25(1):1397-1399,
1993.
162.
Mor E, Jennings
L, Gonwa TA, Holman MJ, Gibbs JF, Solomon H, Goldstein RM, Husberg BS, Watemberg
IA, and Klintmalm GBG. The
impact of operative bleeding on outcome in liver transplantation. Surg, Gyn & Ob 176:219-227,
1993.
163.
Klintmalm
G, Bell M,
Husberg B, Holman M, Goldstein R, Ramsay M, and Polter D: Liver transplant in complete situs
inversus: a case report. Surgery 114(1):102-106,
1993.
164.
Backman L, Gibbs
J, Levy M, McMillan R, Holman M, Husberg B, Goldstein R, Gonwa T, and
Klintmalm G: Causes of late
graft loss after liver transplantation.
165.
McDiarmid S,
Klintmalm G, and Busuttil R:
FK506 conversion for intractable rejection of the liver allograft. Trans Int 6:305-312,
1993.
166.
Han KH,
Hollinger FB, Noonan CA, Solomon H, Klintmalm GB, Genta RM, and Yoffe B.
Southern-blot analysis and simultaneous in situ detection of hepatitis B
virus-associated DNA and antigens in patients with end-stage liver disease. Hepatology 18(5): 1032-8,
1993.
167.
Goldstein R,
Stone M, Tillery G. Senzer N, Levy M, Husberg B, Gonwa T, and Klintmalm
G: Is liver transplantation
indicated for cholangiocarcinoma?
American Journal of Surgery 166:768-772,
1993.
168.
Husberg B, Genyk
Y, and Klintmalm G: A new
rat model for studies of the ischemic injury after transplantation of fatty
livers: improvement after postoperative administration of prostaglandin
(PGE1).
169.
Nikaein A,
Collins R, Klintmalm G, Poole T, Fay J, and Stone M: Immunologic monitoring of
graft-versus-host-disease following orthotopic liver transplantation.
170.
Backman L, Nicar
M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa T,
and Klintmalm G: FK506
trough levels in whole blood and plasma in liver transplant-recipients:
Correlation with clinical events and side effects.
171.
Klintmalm
G: A review of FK506: A new immunosuppressant agent for the
prevention and rescue of graft rejection.
172.
Klintmalm
G: FK506: An update. Clin Trans 8:207-210,
1994.
173.
Klintmalm
G and Stone
M: The results of liver
transplantation with adjuvant chemotherapy for hepatobiliary surgery. J Hepato-Biliary-Pancreatic Surg
2:141-144, 1994.
174.
Nikaein A,
Backman L, Jennings L, Levy M, Goldstein R, Gonwa T, Stone M, and Klintmalm
G: HLA compatibility and liver transplant outcome: Improved patient survival
by HLA and crossmatching.
175.
Busuttil R,
McDiarmid S, Klintmalm G, Goldstein R, Miller C, Schwartz M, Shaw B,
Roberts J, Herbert M, Esquivel C, Nakazato P, Wiesner R, Krom R, Kalayoglu M,
D'Alessandro A, Marsh J, Peters M, Burdick J, Klein A, Lewis W, Jenkins R,
Thistlethwaite J, Emond J, Jusko W, D'Ambrosio R, Buell D, and Fitzsimmons
W: A comparison of tacrolimus
(FK506) and cyclosporine for immunosuppression in liver transplantation. N Eng J Med 331:1110-1115,
1994.
176.
Abouljoud M,
Levy M, Rees C, Diamond N, Lee S, Mulligan D, Goldstein R, Husberg B, Gonwa T,
and Klintmalm G: A
comparison of treatment with transjugular intrahepatic portosystemic shunt or
distal splenorenal shunt in the management of variceal bleeding prior to liver
transplantation.
177.
Gonwa T,
Klintmalm G, Jennings L, Goldstein R, and Husberg B: The impact of pre-transplant renal
function on survival following liver transplantation.
178.
Mor E, Tillery
W, Solomon H, Netto G, Watemberg I, and Klintmalm GB. The predictive value of
hepatocyte glycogen content on liver allograft biopsy. Correlation with early
graft function. Transplantation
59(1):141-3, 1995.
179.
Klintmalm
G: Who should receive the allograft: The transplant center or the
recipient? Liver
180.
Gonwa TA, Klintmalm GB, Levy M,
181.
Levy M, Jennings
L, Abouljoud M, Mulligan D, Goldstein R, Husberg B, Gonwa T, and Klintmalm
G: Quality of life improvements
at one, two and five years after liver transplantation.
182.
Jusko WJ,
Piekoszewski W, Klintmalm GB,
Shaefer MS, Hebert MF, Piergies AA, Lee CC, Schechter P, and Mekki QA.
Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther 57(3):281-90,
1995.
183.
Diamond N, Lee
S, Niblett R, Rees C, and Klintmalm G: Metallic stents for the treatment
of intrahepatic biliary strictures after liver transplantation. Journal of Vascular and
Interventional Radiology 6:755-761, 1995.
184.
Scholz T,
Backman L, Mathisen O, Buo L, Karlsrud T, Johansen H, Bergan A, Klintmalm
G, and Aasen A: Activation of
the plasma contact system and hemodynaic changes after graft revascularization
in liver transplantation.
185.
Mulligan D,
Gentry L, Dombrausky L, Klintmalm G, and Nikaein A: Monitoring of allograft recipients for
the development of HLA-specific antibodies: elimination of OKT3 as a complicating
factor. Clin Trans: 438-441,
1995.
186.
187.
Klintmalm
G and Gonwa
T: Nephrotoxicity associated with
cyclosporine and FK506. Liver
188.
Holman
M, Harrison D, Stewart A, Stone M, Goldstein R, Husbert B, and Klintmalm
G. Neoadjuvant chemotherapy and orthotopic liver transplantation for
hepatocellular carcinoma. N J Med
92(8): 519-22, 1995.
189.
Collins
RH Jr and Klintmalm GB. Aplastic anemia after liver transplantation. Hepatology 22(3):1011-2,
1995.
190.
Lake
JR, Gorman KJ, Esquivel CO, Wiesner RH, Klintmalm GB, Miller CM,
Shaw BW, and Gordon JA. The impact of immunosuppressive regimens on the cost of
liver transplantation—results from the US FK 506 multicenter trial. Transplantation 60(10):1089-95,
1995.
191.
Tong AW, Su D,
Mues G, Tillery GW, Goldstein R, Klintmalm G, and Stone MJ:
Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in
post-liver transplant patient plasma. Clin Cancer Research 2:531-539,
1996.
192.
Busuttil RW, Klintmalm GB, Lake JR, Miller CM, and
Porayko M. General guidelines for the use of tacrolimus in adult liver
transplant patients. Transplantation
61(5):845-7, 1996.
193.
Klintmalm
GB: Clinical use
of FK506 in liver transplantation. Trans Proc 28(2):974-976,
1996.
194.
Miller M,
Crippin J, and Klintmalm GB: End stage liver disease in a 13-year
old secondary to hepatitis C and hemochromatosis. American
Journal of
195.
Gerhardt T,
Goldstein R, Urschel H, Tripp L, Levy M, Husberg G, Jennings L, Gonwa T, and
Klintmalm G: Alcohol use following liver transplantation for alcoholic
cirrhosis.
196.
Kazachkov Y,
Khaoustov V, Yoffe B, Solomon H, Klintmalm GBG, and E Tabor: p53
abnormalities in hepatocellular carcinoma from United States patients: analysis
of all 11 exons.
Carcinogenesis Vol. 17 No.10 pp. 2207-2212,
1996.
197.
Brooks BK, Levy
MF, Jennings LW, Abbasogulu O, Vodapally M, Goldstein RM, Husberg BS, Gonwa TA,
and Klintmalm GB: Influence of donor and recipient gender on the outcome
of liver transplantation.
198.
Peltekian KM,
Makowka L, Williams R, Blendis LM, Levy GA, and the Prostaglandins in Liver
199.
Collins R,
Sackler M, Pitcher C, Waldrop S, Klintmalm G, Jenkins R, and Picker
L: Immune reconstitution with
donor-derived memory/effector T cells after orthotopic liver transplantation.
Experimental Hematology 25:147-159, 1997.
200.
Abbasoglu O,
Levy M, Vodapally M, Goldstein R, Husberg B, Gonwa T, and Klintmalm G:
Hepatic artery stenosis after liver transplantation--incidence, presentation,
treatment, and long term outcome.
201.
Fabia R, Travis
DL, Levy MF, Husberg BS, Goldstein RM, and Klintmalm GB: Effect of
pentoxifylline on porcine hepatic ischemia and reperfusion injury.
Surgery 121(5):520-525, 1997.
202.
Ramsay M,
Simpson B, Nguyen A, Ramsay K, East C, and Klintmalm G: Severe pulmonary
hypertension in liver transplant candidates. Liver
203.
Ramsay MAE, Schmidt A, Hein HAT, Nguyen
A, Lynch K, East CA, Ramsay KJ, and Klintmalm GBG: Nitric oxide does not
reverse pulmonary hypertension associated with end-stage liver disease: a
preliminary report. Hepatology 25(3):524-527, 1997.
204.
Ricci P, Therneau TM, Malinchoc M, Benson
JT, Petz JL, Klintmalm GB, Crippin JS, Wiesner RH, Steers JL, Rakela J,
Starzl TE, and Dickson ER. A prognostic model for the outcome of liver
transplantation in patients with cholestatic liver disease. Hepatology
25(3):672-677, 1997.
205.
The
U.S. Multicenter Liver Study Group (Sher LS, Cosenza CA, Michel J, Makowka L,
Miller CM, Schwartz ME, Busuttil R, McDiarmid S, Burdick JF, Klein AS, Esquivel
C, Klintmalm G, Levy M, Roberts JP, Lake JR, Kalayoglu M, D’Alessandro
AM, Gordon RD, Stieber AC, Shaw BW Jr, Thistlethwaite JR, Whittington P, Wiesner
RH, Porayko M, Bynon JS, Eckhoff DE, Freeman RB, Rohrer RJ, Lewis WD, Marsh JW,
Peters M, Powelson J, and Cosimi AB). Efficacy of tacrolimus as rescue therapy
for chronic rejection in orthotopic liver transplantation.
206.
207.
Jeyarajah DR, McBride M, Klintmalm
GB, and Gonwa TA. Combined liver-kidney transplantation: what are the
indications?
208.
Pelosi F, Klintmalm GBG, Simon WS,
and Roberts WC. Liver
transplantation after coronary bypass grafting. Am J Cardiol
79(10):1405-1407, 1997
209.
Abbasoglu O, Levy MF, Brkic BB, Testa G,
Jeyarajah DR, Goldstein RM, Husberg BS, Gonwa TA, and Klintmalm GB. Ten
years of liver transplantation.
210.
Jeyarajah DR, Gonwa TA, McBride M, Testa
G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, and Klintmalm GB.
Hepatorenal syndrome: combined liver kidney transplants versus isolated liver.
211.
Testa G and Klintmalm GB. Liver
transplantation for primary and metastatic liver cancers. Annals of
212.
Kaspar MD,
Ramsay AE, Shuey CB, Levy MF, and Klintmalm GGB. Severe pulmonary
hypertension and amelioration of hepatopulmonary syndrome after liver
transplantation: case report. Liver
213.
Fabia R, Levy MF, Crippin J, Tillery W,
Netto GJ, Aguanno J, Dysert P, Goldstein RM, Husberg, Gonwa TA, and Klintmalm
GB. De Novo hepatitis B infection after liver transplantation: source of
disease, incidence, and impact. Liver
214.
Prabhakar G,
Testa G, Abbasoglu O, Jeyarajah DR, Goldstein RM, Levy MF, Husberg BS, Gonwa TA,
and Klintmalm GB. The safety of cardiac operations in the liver
transplant recipient. Ann Thorac Surg 65:1060-1064,
1998.
215.
Testa G,
Goldstein RM, Netto G, Abbasoglu O, Brooks BK, Levy MF, Husberg BS, Gonwa TA,
and Klintmalm GB. Long-term outcome of patients transplanted with livers
from hepatitis C-positive donors.
216.
Testa G,
Goldstein RM, Toughanipour A, Abbasoglu O, Jeyarajah DR, Levy M, Husberg BS,
Gonwa TA, and Klintmalm GB. Guidelines for surgical procedures after
liver transplantation. Ann Surg 227(4):590-599,
1998.
217.
Kim WR, Wiesner
RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB,
Crippin JS, Krom RA, and Dickson ER. Optimal timing of liver transplantation for
primary biliary cirrhosis. Hepatology 28(1):33-38,
1998.
218.
The U.S. FK506
Study Group (Klintmalm GB, Goldstein R, Miller CM, Schwartz, Shaw BW,
Roberts JP, Hebert MF, Esquivel CO, Nakazato P, Krom RAF, Kalayoglu M,
D’Alessandro AM, Marsh JW, Peters MG, Burdick J, Klein A, Lewis WD, Jenkins R,
Thistlethwaite JR, Edmond JC, Gadgil S, and Facklam DP). A long-term comparison
of tacrolimus (FK506) versus cyclosporine in liver transplantation.
219.
Jeyarajah DR,
Gonwa TA, Testa G, Abbasoglu O, Goldstein R, Husberg BS, Levy MF, and
Klintmalm GB. Liver and kidney transplantation for polycystic disease.
220.
Fabia R, Levy
MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS, Gonwa TA, and Klintmalm
GB.
221.
Klintmalm
GB. Liver
transplantation for hepatocellular carcinoma: a registry report of the impact of
tumor characteristics on outcome. Ann Surg 228(4):479-490,
1998.
222.
Klintmalm
GB. Why
immunology? BUMC Proceedings 11(4):207-208, 1998.
223.
Kazachkov Y,
Yoffe B, Khaoustov VI, Solomon H, Klintmalm GBG, and Tabor E.
Microsatellite instability in human hepatocellular carcinoma: relationship to
p53 abnormalities. Liver 18:156-161, 1998.
224.
Abbasoglu O,
Goldstein RM, Vodapally MS,
225.
Jeyarajah DR,
Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa
TA, Tillery GW, Crippin JS, and Klintmalm GB. Recurrent primary
sclerosing cholangitis after orthotopic liver transplantation: is chronic
rejection part of the disease process?
226.
Prabhakar G,
Testa G, Abbasoglu O, Jeyarajah DR, Goldstein RM, Levy MF, Husberg BS, Gonwa TA,
and Klintmalm GB. The safety of cardiac operations in the liver
transplant recipient. Annals of Thoracic Surgery 65:1060-1064,
1998.
227.
Travis DL, Fabia
R, Netto GG, Husberg BS, Goldstein RM, Klintmalm GB, and Levy MF.
Protection by cyclosporine A against normothermic liver ischemia-reperfusion in
pigs. Journal of Surgical Research 75(2):116-126,
1998.
228.
Abbasoglu O,
Levy MF, Testa G, Obiekwe S, Brkic BS,
229.
Gross CR,
Malinchoc M, Kim WR, Evans RW, Wiesner TH, Petz JL, Crippin JS, Klintmalm
GB, Levy MF, Ricci P, Therneau TM, and Dickson ER. Quality of life before
and after liver transplantation for cholestatic liver disease. Hepatology
29(2):356-64, 1999.
230.
Ramsay MAE,
Spikes C, East CA, Lynch K, Hein HAT, Ramsay KJ, and Klintmalm GBG. The
perioperative management of portopulmonary hypertension with nitric oxide and
epoprostenol. Anesthesiology: Case Report. 90(1):299-301,
1999.
231.
Markmann JF,
Gornbein J, Markowitz JS, Levy MF, Klintmalm GB, Yersiz H, Morrisey M,
Drazan K, Farmer DG, Ghobrial RM, Goss J, Seu P, Martin P, Goldstein LI, and
Busuttil RW. A simple model to estimate survival after retransplantation of the
liver.
232.
Scholz T,
Gallimore MJ, Backman L, Mathisen O, Bergan A, Klintmalm GB, and Aasen
AO. Plasma proteolytic activity in liver transplant rejection. Transpl
Int 12:100-107, 1999.
233.
Simpson RI,
Ramsay MAE, Lynch K, Ramsay KJ, Tillmann Hein HA, Crippin JS, Sarles HE, Black
RD, East CA, Escobar JM, Goldstein RM, Husberg BS, Levy MF, and Klintmalm
GBG. Paradoxical role of inhaled nitric oxide in advanced liver disease.
BUMC Proceedings 12(4):223-225, 1999.
234.
Kim WR, Wiesner
RH, Poterucha JJ, Therneau TM, Malinchoc M, Benson JT, Crippin JS, Klintmalm
GBG, Rakela J, Starzl TE, Krom RAF, Evans RW, and Dickson ER. Hepatic
retransplantation in cholestatic liver disease: impact of the interval to
retransplantation on survival and resource utilization. Hepatology
30(2):395-400, 1999.
235.
Klein, Andrew
and the U.S. Multicenter FK506 Liver Study Group. Tacrolimus rescue in liver
transplant patients with refractory rejection or intolerance or malabsorption of
cyclosporine. Liver
236.
Levy MF, Crippin
J, Sutton S, Netto G, Jeff McCormack, Curiel T, Gold tein RM, Newman JT, Gonwa
TA, Banchereau J, Diamond, LE, Byrne G, Logan J, and Klintmalm GB. Liver
allotransplantation after extracorporeal hepatic support with transgenic
(hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human
transmission of the porcine endogenous retrovirus.
237.
Tong MJ,
Terrault NA, and Klintmalm G. Hepatitis B transplantation: special
conditions. Sem Liver Dis 20 (Suppl. 1):25-28, 2000.
(moderator)
238.
Cowling T,
239.
Molmenti EP,
Klintmalm GB. Hepatitis C recurrence after liver transplantation.
Liver
240.
Testa G, Crippin
JS, Netto GJ, Goldstein RM,
241.
Molmenti EP and
Klintmalm GB. Cancer and liver transplantation.
242.
Levy MF,
Somasundar PS,
243.
Levy MF, Greene
L, Ramsay MAE, Jennings LW, Ramsay KJ, Meng J, Hein HAT, Goldstein RM, Husberg
BS, Gonwa TA, and Klintmalm GB. Readmission to the ICU following liver
transplantation. Critical Care Medicine 29(1):18-24,
2001.
244.
Wiesner R, Rabkin J, Klintmalm G,
McDiarmid S, Langnas A, Punch J, McMaster P, Kalayoglu M, Levy G, Freeman R,
Bismuth H, Neuhaus P, Mamelok R, and Wang W. A randomized double-blind
comparative study of mycophenolate mofetil and azathioprine in combination with
cyclosporine and corticosteroids in primary liver transplant recipients.
Liver
245.
Gonwa TA, Mai ML, Melton LB, Hays SR,
Goldstein RM, Levy MF, and Klintmalm GB. Renal replacement therapy and
orthotopic liver transplantation: The role of continuous veno-venous
hemodialysis.
246.
Molmenti EP, Molmenti H, Marubashi S,
Sanchez EQ, Gogel B, Goldstein RM, Levy MF, Fasola CG, Gonwa TA, and
Klintmalm GB. Cannulations of the aorta in organ donors with aortic and
caval injuries at the time of procurement. Pediatr
247.
Molmenti EP, Nagata DE, Roden JS, Squires
RH, Molmenti H, Fasola CG, Winick N, Tomlinson G, Lopez MJ, D’Amico L, Dyer HL,
Savino AC, Sanchez EQ, Levy MF, Goldstein RG, Andersen JA, and Klintmalm
GB. Posttransplant
lymphoproliferative syndrome in the pediatric liver transplant population.
American Journal of
248.
Gonwa TA, Mai
ML, Melton LB, Hays SR, Goldstein RM, Levy MF, and Klintmalm GB. End stage renal disease (ESRD) after
orthotopic liver transplantation (OLTX) using calcineurin based immunotherapy:
risk of development and treatment.
249.
Molmenti EP,
Molmenti H, Marubashi S, Sanchez EQ, Gogel BM, Goldstein RM, Levy ML, Fasola CG,
Gonwa TA, and Klintmalm GB. Cannulation of the aorta in organ donors with
Infrarenal Aortic Pathologies. Digestive Diseases and Sciences 46
(11):2457-2459, 2001.
250.
Scholz T,
Solberg R, Okkenhaug C., Videm V, Gallimore MJ, Mathisen O, Pedersen T, Mollnes
TE, Bergan A, Soreide O, Klintmalm
GB, and Aasen AO. Veno-venous bypass in liver transplantation:
heparin-coated perfusion circuits reduce the activation of humoral defense
systems in an in vitro model. Perfusion 16(4), 285-292,
2001.
251.
Klintmalm
GB. Marketing –
what is it? Graft 4(6):421-423, 2001.
252.
Scholz T,
Solberg R, Okkenhaug C, Videm V, Gallimore MJ, Mathisen O, Mollnes TE, Bergan A,
Soreide O, Klintmalm GB, and Aasen
AO. The significance of heparin-coated veno-venous bypass circuits in liver
transplantation. Perfusion 17(1):45-50, 2002.
253.
Molmenti EP,
Roodhouse TW, Molmenti H, Jaisway K, Jung GJ, Marubashi S, Sanchez EQ, Gogel B,
Levy MF, Goldstein RM, Fasola CG, Elliott EE, Bursac N, Mulligan D, Gonwa TA,
and Klintmalm GB. Thrombendvenectomy for organized portal
vein thrombosis at the time of liver transplantation. Annals of Surgery
235(2): 292-296, 2002.
254.
Molmenti EP,
Levy MF, Molmenti H, Casey D, Fasola CG, Hamilton WM, Ghapjoong J, Marubashi S,
Gogel BM, Goldstein RM, Gonwa TA, and Klintmalm GB. Correlation between
intraoperative blood flows and hepatic artery strictures in liver
transplantation. Liver
255.
Sanchez EQ,
Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA,
Jennings LW, Brooks BK, and Klintmalm
GB. DeNovo tumors after liver transplantation: a single-institution
experience. Liver
256.
Gonwa TA, Mai
ML, Melton LB, Levy MF, Goldstein RM, and Klintmalm GB. Immunosuppression for delayed or slow
graft function in primary cadaveric renal transplantation: Use of low dose
tacrolimus therapy with postoperative administration of anti-CD25 monoclonal
antibody. Clin Transplant
16(2):144-149, 2002.
257.
Molmenti EP,
Netto GJ, Murray NG, Smith DM, Molmenti H, Crippin JS, Hoover TC, Jung GJ,
Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Gonwa TA,
and Klintmalm GB. Incidence and recurrence of autoimmune/alloimmune
hepatitis in liver transplant recipients. Liver
258.
Molmenti EP,
Wilkinson K, Molmenti H, Roden JS, Squires RH, Fasola CG, Tomlinson G, Nagata
DE, D’Amico L, Lopez MJ, Savino LM, Marubashi S, Sanchez ES, Goldstein RM, Levy
MF, Andrews W, Andersen JA, and Klintmalm GB. Treatment of unresectable hepatoblastoma
with liver transplantation in the pediatric population. American Journal of
259.
Fasola CG and
Klintmalm GB. Letter to the Editor: Hepatitis C and mycopholate mofetil –
a clarification. Liver
260.
Molmenti EP
and Klintmalm GB. Liver transplantation in association
with hepatocellular carcinoma: an update of the international tumor
registry. Liver
261.
Melear JM,
Goldstein RM, Levy MF, Molmenti EP, Cooper B, Netto GJ, Klintmalm GB, and
Stone MJ. Hematologic aspects of liver transplantation for budd-chiari syndrome
with special reference to myeloproliferative disorders.
262.
Molmenti EP,
Smith DM, Molmenti H, Fasola CG, Aguanno JJ, Savino AC, Peterson TS, Barshes V,
Levy MF, Goldstein RM, and Klintmalm
GB. Unusually high incidence of positive HTLV I/II Results among young
female organ donors in the peripartum period. Digestive Diseases and Sciences 47
(11):2383-2385, 2002.
263.
Yoon D,
Kueppers F, Genta RM, Klintmalm GB,
Khaoustov VI, and Yoffe B. Role of alpha-1-antichymotrypsin deficiency in
promoting cirrhosis in two siblings with heterozygous alpha-1-antitrypsin
deficiency phenotype SZ. Gut
50(5):730-2, May 2002.
264.
Onaca NN,
Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, Weinstein JS, Murray
NG, Goldstein RM, and Klintmalm GB.
A correlation between the pretransplantation MELD score and mortality in the
first two years after liver transplantation. Liver
265.
Smith DM,
Agura E, Netto G, Collins R, Levy M, Goldstein R, Christensen L, Baker J,
Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson DB, Domiati-Saad R,
Stone M, and Klintmalm G. Liver transplant-associated
graft-versus-host disease.
266.
Molmenti EP,
Molmenti H, Weinstein J, Elliott EE, Fasola CG, Orr D, Blum J, Savino D,
Hamilton WM, Goldstein RM, Levy MF, and Klintmalm GB. Syndromic incidence of ovarian carcinoma
after liver transplantation, with special reference to anteceding breast cancer.
Digestive Diseases and Sciences 48
(1):187-189, 2003.
267.
Sanchez EQ,
Goldstein RM, Klintmalm GB, and Levy
MF. Porcine hepatocytes for use in bioartificial liver support. Verdauungskrankheiten Jahrgang 21
(1):24-31, 2003.
268.
Molmenti EP,
Squires RH, Nagata D, Roden JS, Molmenti H, Fasola CG, Prestidge C, D’Amico L,
Casey D, Sanchez EQ, Goldstein RM, Levy MF, Benser M, McPhail W, Andrews W,
Andersen JA, and Klintmalm GB. Liver
transplantation for cholestasis associated with cystic fibrosis in the pediatric
population. Pediatr
269.
Onaca NN,
Levy MF, Netto, GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, Fasola CG, Weinstein
JS, Murray N, Goldstein RM, and Klintmalm GB. Pretransplant MELD score as a predictor
of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 3(5):626-630,
2003.
270.
Onaca N,
Goldstein RM, Levy MF, and Klintmalm
GB. Baylor Regional Transplant Institute: an update on liver, kidney, and
pancreas transplantation. BUMC
Proceedings 16:297-301, 2003.
271.
Onaca N,
Goldstein RM, and Klintmalm GB.
Xanthomas disappear rapidly after liver transplantation for familial
hypercholesterolemia. Liver
Transplantation 9(12): 1334-5, 2003.
272.
Gonwa TA, Mai
ML, and Klintmalm GB. Chronic renal
failure after transplantation of a nonrenal organ. N Engl J Med 349(26): 2563-2565,
2003.
273.
Sanchez EQ,
Levy MF, Goldstein RM, Fasola CG, Tillery GW, Netto GJ, Watkins DL, Weinstein
JS, Murray NG, Byers D, Christensen LL, and Klintmalm GB. The changing clinical
presentation of recurrent primary biliary cirrhosis after liver
transplantation. Transplantation 76(11): 1583-1588,
2003.
274.
Cowling T,
275.
Cowling T,
276.
Kefalas CH,
Murray NGB, Aguanno JJ, Docker WD, Weinstein JS,
277.
Gonwa TA,
278.
Guirl MJ,
Goldstein RM, Levy MF, Klintmalm GB,
and Weinstein JS. Two stage total hepatectomy and liver transplantation for
acute deterioration of chronic liver disease: a new bridge to transplantation.
Liver Transplantation 10(4): 564-70,
2004.
279.
Martin P,
Busuttil RW, Goldstein RM, Crippin JS, Klintmalm GB, Fitzsimmons WE, and
Uleman C. Impact of tacrolimus
versus cyclosporine in hepaititis C virus-infected liver transplant recipients
on recurrent hepatitis: a prospective, randomized trial. Liver Transpl 10(10): 1258-1262,
2004.
280.
Levy G,
Villamil F, Samuel D, Sanjuan F, Grazi G, Wu Y, Marotta P, Boillot O, Muelbacher
F, Klintmalm G, and LIS2T Study
Group. Results of LIS2T, a multicenter, randomized study comparing cyclosporine
microemulsioin with C2 monitoring and tacrolimus C0 monitoring in de novo liver
transplantation. Transplantation
77(11):1632-8, 2004.
281.
Arenas JI,
Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib Am, Fasola C, Adair D,
Radowski M, Kibler KV, Nowicki M, Douglas D, Williams J, NEtto G, Mulligan D, Klintmalm G, Rakela J, and Vargas HE.
Hepatitis C virus quasispecies dynamics predict fibrosis progression after liver
transplantation. J of Infect Dis
189(11): 2037-46, 2004
282.
Onaca N, Klintmalm GB, and Levy MF. Pancreatic
islet cell transplantation: a treatment strategy for type I diabetes
mellitus. Nutrition in Clinical Practice
19(2):154-164, 2004.
283.
Brown RS,
Rush SH, Rosen HR, Langnas AN, Klintmalm
GB, Hanto DW, and Punch JD. Liver and intestine transplantation. American Journal of Transplantation
4(9): 81-92, 2004.
284.
Peters TG,
Spinola KN, West JC, Aeder MI, Danovitch GM, Klintmalm GBG, Gorman KJ, Gordon JA,
Kincaid CH, and First MR.
Differences in Patient and Transplant Professional Perceptions of
Immunosuppression-Induced Cosmetic Side Effects. Transplantation 78(4): 537-543,
2004
285.
Sanchez EQ,
Gonwa TA, Levy MF, Goldstein RM, Mai MM, Hays SR, Melton LB, Saracino G, and Klintmalm GB. Pre and perioperative predictors of the
need for renal replacement therapy (RRT) following orthotopic liver
transplantation (OLTX). Transplantation 78(7): 1048-1054,
2004.
286.
Florman S,
Alloway R, Kalayoglu M, Lake K, Bak T, Klein A, Klintmalm G, Busque S, Brandenhagen D,
Lake J, Wisemandle K, Fitzsimmons W, and First MR. Conversion of stable liver transplant
recipients from a twice-daily Prograf-based regimen to a once-daily modified
release tacrolimus-based regimen.
Transplant Proc
37(2):1211-1213, 2005.
287.
Srinivasan A,
Burton EC, Kuehnert MJ, Rupprecht C, Sutker WL, Ksiazek TG, Paddock CD, Guarner
J, Shieh WJ, Goldsmith C, Hanlon CA, Zoretic J, Fischbach B, Niezgoda M, El-Feky
WH, Orciari L, Sanchez EQ, Likos A, Klintmalm GB, Cardo D, LeDuc J,
Chamberland ME, Jernigan DB, Zaki SR, and Rabies in Transplant Recipients
Investigation Team. Transmissioni
of rabies virus from an organ donor to four transplant recipients. N
Engl J Med 352(11):1103-1111, 2005.
288.
Lucey MR,
Abdelmalek MF, Gagliardi R, Granger D, Holt C, Kam I, Klintmalm G, Langnas A, Shetty K,
Tzakis A, and Woodle ES. A
comparison of tacrolimus and cyclosporine in liver transplantation: effects on
renal function and cardiovascular risk status. Am J Transplant 5(5):1111-1119,
2005.
289.
Cowling T,
Jennings LW, Goldstein RM, Sanchez EQ, Chinnakotla S, Dawson S,
290.
Singh N,
Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, Munoz P, Klintmalm GB, Stosor V, del Busto R,
Limaye AP, Somani J, Lyon M, Houston S, House AA, Pruett TL, Orloff S, Humar A,
Dowdy L, Garcia-Diaz J, Kalil AC, Fisher RA, Husain S, and Cryptoccal
Collaborative Transplant Study Group.
An immune reconstitution syndrome-like illness associated with
Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 40(12):1756-1761,
2005.
291.
Burton EC,
Burns DK, Opatowsky MJ, El-Feky WH, Fischbach B, Melton L, Sanchez E, Randall H,
Watkins DL, Chang J, and Klintmalm
G. Rabies encephalomyelitis: clinical, neuroradiological, and pathological
findings in 4 transplant recipients. Arch
Neurol 62(6):873-882, 2005.
292.
Planinsic RM,
van der Meer J, Testa G, Grande L, Candela A, Porte RJ, Ghobrial RM, Isoniemi H,
Schelde PB, Erhardtsen E, Klintmalm
G, and Emre S. Safety and
efficacy of a single bolus administration of recombinant factor VIIa in liver
transplantation due to chronic liver disease. Liver Transpl 11(8):895-900,
2005.
293.
Onaca N,
Sanchez EQ, Melton LB, Netto GJ, Glastad KA, Martin PA, Ueno T, Levy MF,
Goldstein RM, and Klintmalm GB.
Cadaveric orthotopic auxiliary split liver transpanatation and kidney
transplantation: an alternative for type 1 primary hyperoxaluria. Transplantation 80(3): 421-4,
2005.
294.
Sanchez EQ,
Martin AP, Kiegami T, Uemura T, Narasimhan G, Goldstein RM, Levy MF, Chinnakotla
S, Dawson S, Randall HB, Saracino G, and Klintmalm GB. Sirolimus conversion after liver
transplantation: improvement in measure glomerular filtration rate after 2
years. Transplantation Proceedings
37:4416-4423, 2005.
295.
Uemura T,
Sanchez EQ, Ikegami T, Watkins D, Narasimhan G, McKenna GJ, Chinnakotla S,
Dawson S,
296.
Singh N,
Lorthoary O, Alexander BD, Gupta KL, John GT, Pursell K, Munoz P, Klintmalm GB, Stosor V, delBusto R,
Limaye AP, Somani J, Lyon M, Houston S, House AA, Pruett TL, Orloff S, Humar A,
Dowdy L, Garcia-Diaz J, Fisher RA, Husain S, and the Cryptococcal Collaborative
Transplant Study Group. Allograft
loss in renal transplant recipients with Cryptococcus neoformans associated
immune reconstitution syndrome. Transplantation 80(8): 1131-1133, Oct.
2005.
297.
Singh N,
Lorthoary O, Alexander BD, Gupta KL, John GT, Pursell K, Munoz P, Klintmalm GB, Stosor V, delBusto R,
Limaye AP, Somani J, Lyon M, Houston S, House AA, Pruett TL, Orloff S, Humar A,
Dowdy L, Garcia-Diaz J, Fisher RA, Husain S, and the Cryptococcal Collaborative
Transplant Study Group. Antifungal
management practices and evolution of infection in organ transplant recipients
with Cryptococcus neoformans infection.
Transplantation
80(8):1033-1039, Oct. 2005.
298.
Domiati-Saad
R, Klintmalm GB, Netto G, Agura ED,
Chinnakotla S, and Smith DM. Acute graft versus host disease after liver
transplantation: patterns of lymphocyte chimerism. Am J Transplant 5:2968-2973,
2005.
299.
Washburn WK,
Teperman LW, Heffron TG, Douglas DD, Gay S, Katz E, and Klintmalm GB. A novel three-dose
regimen of daclizumab in liver transplant recipients with hepatitis C: a
pharmacokinetic and pharmacodynamic study.
Liver Transpl 12(2),
2006.
300.
Singh N,
Limaye AJ, Forrest G, Safdar N, Munoz P, Pursell K, Houston S, Rosso F, Montoya
JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM,
Lewis RE, Kontoyiannis DP, and Husain S. Combination of voriconazole and
caspfungin as primary therapy for invasive aspergillosis in solid organ
transplant recipients: a prospective, multicenter, observational study. Transpl 81(3),
2006.
301.
Biggins SW,
Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers
W, Wiesner R, Kamath P, and Klintmalm
G. Evidence-based incorporation of serum socium concentration into MELD. Gastroenterology – accepted for
publication, 2006.
302.
Ueno T, Jones
G, Martin A, Ikegami T, Sanchez EQ, Chinnakotla S, Randall HB, Levy MF,
Goldstein RM, and Klintmalm GB.
Clinical outcomes from hepatic artery stenting in liver transplantation. Liver Transplantation 12:522-427,
2006.
303.
Onaca N, Levy
MF, Ueno T, Martin AP, Sanchez EQ, Chinnakotla S, Randall HB, Dawson S,
Goldstein RM, Davis GL, and Klintmalm
GB. An outcome comparison
between primary liver transplantation and retransplantation based on the
pretransplant MELD score. Transplant International 19:282-287,
2006.
304.
Smith DM,
Agura ED, Levy MF, Melton LB, Domiati-Saad R, and Klintmalm G. Graft vs. host disease following kidney
transplantation using a ‘0 HLA antigen mismatched’ donor. Nephrol Dial Transplant
2006.
305.
Netto GJ,
Altrabulsi B, Katabi N, Martin P, Burt K, Levy M, Sanchez E, Watkins DL,
Jennings L, Klintmalm G, and
Goldstein R. Radio frequency
ablation of hepatocellular carcinoma prior to liver transplantation: a
histologic and TUNEL study. Liver International 26:746-751,
2006.
306.
Netto GJ,
Colby T, Williams JW, Sharky F, Corless C, Lewin D, Petrovic L, Kanel G, Theise
N, Klintmalm G, and the Hepatitis C
3 Trial Group. Interobserver
agreement in hepatitis C grading and staging and
307.
Martin AP,
Goldstein R, Dempster J, Netto GJ, Katabi N, Derrick HC, Altrabulsi B, Jennings
L, Ueno T, Chinnakotla S, Dawson III, S, Randall HB, Levy MF, Onaca N, Sanchez
EQ, Orr D, Klintmalm GB. Radiofrequency thermal ablation of
hepatocellular carcinoma before liver transplantation – a clinical and
histological examination. Clinical Transplantation 20:695-705,
2006.
308.
Fazola CG and
Klintmalm GB. Hepatitis C recurrence after liver
transplantation: in search of the optimal immunosuppression to improve outcome.
Current opinion in Organ Transplantation
2006, 11:637-642.
309.
Chinnakotla
S, Smith DM, Domiati-Saad R, Agura ED, Watkins DL, Netto G, Uemura T, Sanchez
EQ, Levy MF and Klintmalm GB. Acute
graft-versus-host disease after liver transplantation: role of withdrawal of
immunosuppression in therapeutice management. Liver Transplantation 13:157-161,
2007
NON-PEER REVIEWED
JOURNALS
1.
Starzl
TE, Hakala TR, Iwatsuki S, Rosenthal TJ, Shaw Jr BW, Klintmalm G, and
Porter KA: Cyclosporin A and steroid treatment in 104 cadaveric renal
transplantations. 365-377. In:
Cyclosporin A:
Proceedings of an International Conference on Cyclosporin A, D.J.G.
White, ed. Elsevier Biomedical Press,
2.
Husberg
BS and Klintmalm GBG:
Rejection treatment with monoclonal OKT3 antibodies after renal
transplantation - a case.
3.
Bryan
CF, Newman JT, Tillquist RL, Husberg B, Klintmalm GB, and Stone MJ: Development of class I-directed
lymphocytotoxic antibodies after liver transplantation. Trans Proc, 19(1)
(February):2392-2393, 1987.
4.
Husberg
BS and Klintmalm GB:
Establishing a center for liver transplantation at baylor university
medical center--a two year perspective.
BUMC Proceedings, 1(1):9-15, January, 1988.
5.
Markus
BH, Duquesnoy RJ,
6.
Husberg
BS, Olson LM, Neely SJ, Nery JR, and Klintmalm GB: Prophylactic low-dose amphotericin B
treatment prevents invasive candida infection in high-risk liver transplant
patients. Trans Proc 20(1)
(Suppl 1) (February):659-660, 1988.
7.
Olson
LM, Klintmalm GB, Husberg BS, and Nery J: Physiological aberrations diagnostic of
hepatic graft nonfunction: a case
report. Trans Proc 20(1)
(Suppl 1) (February):667-668, 1988.
8.
Fehrman
I, Greene CL, Tillery W, Klintmalm G, and Husberg B: Liver transplant aspiration cytology as
a clinical tool for diagnosing allograft rejection. Trans Proc 20(1) (Suppl 1)
(February):685-686, 1988.
9.
Greene
CL, Fehrman I, Tillery GW, Husberg BS, and Klintmalm GB: Liver transplant aspiration cytology is
a useful tool for identifying and monitoring allograft rejection. Trans
Proc 20(1) (Suppl 1) (February):687-688, 1988.
10.
Ramsay
MAE, Klintmalm G, Brajtbord D, Swygert T, Valek TR, and Paulsen AW: Air embolism during liver
transplantation. (Letter to the
Editor) Anesthesiology 68:829-830, 1988.
11.
Makowka
L, Sher L, Kahn D, Tzakis AG, Todo S, Marsh JW, Stieber A, Koneru B,
Klintmalm GBG, Staschak SM, Iwatsuki S, Gordon RD, Van Thiel D, and
Starzl TE: Liver
transplantation: a guideline for patient evaluation.
12.
Tillery
W, Demetris J, Watkins D, Goldstein R, Poplawski S, Husberg B, and Klintmalm
G: Pathologic recognition of
preservation injury in hepatic allografts with six months follow-up. Trans Proc 21(1)
(February):1330-1331, 1989.
13.
Edwards
LC, Nikaein A, Bryan C, Gonwa T, Klintmalm G, Husberg B, White M, and
Stone MJ: The predictive role of
immunologic tests in liver transplant rejection. Trans Proc 21(1)
(February):2282-2283, 1989.
14.
Paulsen
AW, Brajtbord D, Klintmalm GB, Ramsay MAE, Valek TR, and Swygert TH: Intraoperative measurements related to
subsequent hepatic graft failure.
Trans Proc, 21(1) (February):2337-2388,
1989.
15.
Secrest
CL, Goldstein RM, Klintmalm GB,
16.
Brajtbord
D, Paulsen AW, Ramsay MAE, Swygert TH, Valek TR, Ramon VJ, Johnson DD, Parks RI,
Pyron JT, Walling PT, and Klintmalm GB: Potential problems with autotransfusion
during hepatic transplantation.
Trans Proc 21(1) (February):2347-2348, 1989.
17.
Paulsen
AW, Valek TR, Ramsay M, Swygert T, and Klintmalm G: Determination of an adequate flush
volume for removal of preservation fluid prior to revascularization of the donor
liver. Trans Proc 21(1)
(February):2349-2350, 1989.
18.
Gonwa
TA, Poplawski S, Paulsen W, Brajtbord D, Goldstein R, Husberg B, and
Klintmalm G: Hepatorenal
syndrome and orthotopic liver transplantation. Trans Proc 21(1)
(February):2419-2420, 1989.
19.
Husberg
B and Klintmalm G:
Portocaval shunt in preparation for emergency liver transplantation.
20.
Klintmalm
GB: Rejection therapies; Presented at the
AASLD Liver Transplant Roundtable,
21.
22.
Mora
NP, Klintmalm GB, Poplawski SS, Cofer JB, Husberg BS, Gonwa TA, and
Goldstein RM: Recurrence of
hepatitis B after liver transplantation:
does hepatitis-B-immunoglobulin modify the recurrent disease? Trans
Proc 22(4) (August):1549-1550, 1990.
23.
Goldstein
R, Clark P, Klintmalm G, Husberg B, Gonwa T, and Stone M: Prevention of recurrent thrombosis
following liver transplantation for budd-chiari syndrome associated with
myeloproliferative disorders: treatment with hydroxyurea and aspirin. Trans Proc 23(1)
(February):1559-1560, 1991.
24.
Turrion
VS, Mora NP, Cofer JB, Solomon H, Morris CA, Gonwa TA, Goldstein RM, Husberg BS,
and Klintmalm GB:
retrospective evaluation of liver transplantation for cirrhosis: a comparative study of 100 patients with
or without previous porto-systemic shunt.
Trans Proc 23(1) (February):1570-1571, 1991.
25.
Goldstein
RM, Klintmalm GK, Husberg BS, Gonwa TA, and Polter D: Liver
transplantation: a review of the
first 200 patients. Trans
Proc 23(2)(April):1991.
26.
Brown
M, Gunning T, Roberts C, Swygert T, Klintmalm GB, Ramsay, MAE and Gonwa
TA: biochemical markers of renal perfusion are preserved during liver
transplantation with venovenous bypass.
Trans Proc 23(3) (June):1980-1981, 1991.
27.
Gibbs
JF, Holman MJ, Travis DL, Genyk YS, Klintmalm GB, and Paulsen AW: Portal vein oxygenation in an isolated
porcine liver perfusion model.
Poster Presentation:
Fellow's Conference on
28.
Klintmalm
G, guest editor of Dallas Medical Journal, Special Transplant Update
Issue, December 1991.
29.
Mora
NP, Klintmalm GB, Solomon H, Goldstein R, Gonwa T, and Husberg B: Selective amphotericin B. prophylaxis in
the reduction of fungal infections after liver transplant. Trans Proc
24(1)(February):154-155, 1992.
30.
Mora
NP, Klintmalm GB, Solomon H, Goldstein RM, Gonwa TA, and Husberg BS: Survival after liver transplantation in
300 consecutive patients: the
influence of age, clinical status, and pretransplant disease. Trans Proc
24(1)(February):156-157, 1992.
31.
Mora
N, Husberg B, Gonwa T, Goldstein R, and Klintmalm G: The impact of the different severe
infections on the outcome of liver transplantation. A study of 150 patients. Trans Int 5(Suppl 1): S209-S210.
1992.
32.
Collins
RH, Cooper C, Nikaein A, Klintmalm G, and Fay J: Letter to the Editor, Annals of
Internal Medicine 117 (15 July):2, 1992.
33.
Klintmalm
G: Liver transplantation: issues in 1992. Presentation: 19th Annual Winter Nephrology Symposium,
34.
Klintmalm
G,
Ascher N, Busuttil R, Deierhoi M, Gonwa T, Kauffman R, McDiarmid S, Poplawski S,
Sollinger H, and Roberts J: RS-61443 for treatment-resistant human liver
rejection. Trans Proc
25(1):697, 1993.
35.
Gibbs
J, Husberg B, Klintmalm G, Backman L, Levy M, Goldstein R, Holman M,
Gonwa T, and Morris C: Outcome
analysis of FK506 therapy for acute and chronic rejection. Trans Proc 25(1):622-623,
1993.
36.
Goldstein
R, Tripp L, Clemons J, Husberg B, Gonwa T, Polter D, and Klintmalm GB:
Liver transplantation for alcoholic cirrhosis -- do they mix? Trans Proc 25(1):1131-1132,
1993.
37.
Stephens
J, Goldstein R, Crippin J, Husberg B, Holman M, Gonwa T, and Klintmalm
GB. Effects of orthotopic liver transplantation and immunosuppression on
inflammatory bowel disease in primary sclerosing cholangitis patients. Trans Proc 25(1):1122-1123,
1993.
38.
Backman
L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, Goldstein R, Gonwa T, and
Klintmalm G: Late graft loss
after liver transplantation: a
study of 434 consecutive patients.
Trans Proc 25(1):1111-1112, 1993.
39.
Sollinger
H, Belzer F, Deierhoi M, Diethelm A, Gonwa T, Kauffman R, Klintmalm G,
McDiarmid S, Roberts J, Rosenthal J, and Tomlanovich: RS-61443: rescue therapy in refractory
kidney transplant rejection.
Trans Proc 25(1):698-699, 1993.
40.
Klintmalm
G,
Ascher N, Busuttil R, Deierhoi M, Gonwa T, Kauffman R, McDiarmid S, Poplawski S,
Sollinger H, and Roberts J:
RS-61443 for treatment-resistant human liver rejection. Trans Proc 25(1):697,
1993.
41.
G.B.
Klintmalm,
J.F. Gibbs, R. McMillan, L. Backman, M. Levy, R.M. Goldstein, B.S. Husberg, M.J.
Holman and T.A. Gonwa.
Rejection: FK 506 for rescue
or maintenance. Trans Proc
25(2):1914-1915, 1993.
42.
Klintmalm
G: FK506 - an update. Presentation: Fourth American Society of Transplant
Surgeons Post Graduate Course,
43.
Gonwa
T, Goldstein R, Holman M, Husberg B, and Klintmalm G: Orthotopic liver transplantation and
renal function: Outcome of
hepatorenal syndrome and trial of verapamil for renal protection in
nonhepatorenal syndrome. Trans
Proc 25(2): 1891-1892,
1993.
44.
Klintmalm
G: The business of transplantation:
Contracts, negotiations, and preferred providers. J Transplant
Coordination 3:147-149, 1993.
45.
Backman
L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B,
Gonwa T, and Klintmalm G:
Chronic nephrotoxicity of FK506 after liver transplantation. Trans Proc 26(3):1803,
1994.
46.
Backman
L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B,
Gonwa T, and Klintmalm G:
Whole blood and plasma levels of FK506 after liver transplantation: Correlation with toxicity. Trans
Proc 26(3):1804, 1994.
47.
Gross
CR,
48.
Dawidson
I, Lu C, Ar'Rajab A, Klintmalm G, Dickerman R, Trevino G, Melone D,
Wallace J, Remmich S, and Risser R:
Perioperative albumin and verapamil improve early outcome after cadaver
renal transplantation. Trans
Proc 26(6):3100-3101, 1994.
49.
Klintmalm
G: Hepatoma and liver transplantation (a
commentary).
50.
Porayko
MK, Gonwa TA, Klintmalm GB, and Wiesner RH. Comparing nephrotoxicity of
FK 506 and cyclosporine regimens after liver transplantation: preliminary
results from
51.
Abouljoud
M, Levy M, Goldstein R, Mulligan D, Husberg B, Gonwa T, Crippin J, and
Klintmalm G: Hyperlipidemia
after liver transplantation: A
randomized trial of FK506 versus Cyclosporine a US multicenter trial. Trans Proc 27(1):1121-1123,
1995.
52.
Backman
L, Klintmalm G, and U.S. FK506 Multicenter Study Group: Whole blood and plasma levels of FK506
after liver transplantation:
Results from the
53.
Nikaein
A, Backman L, Jennings L, Levy M, Goldstein R, Gonwa T, Stone M, and Klintmalm G. HLA compatibility and
liver transplant outcome: improved patient survival by HLA and crossmatching. Trans Proc 27(1):1186-8,
1995.
54.
Mulligan
D, Goldstein R, Crippin J, Abouljoud M, Levy M, Husberg B, Gonwa T, Foster B,
Tillery G, and Klintmalm G:
The use of anti-hepatitis C virus seropositive organs in liver
transplantation. Trans Proc
27(1):1204-1205, 1995.
55.
Fabia
R, Levy M, Travis D, Goldstein M, Husberg B, and Klintmalm G: The effect
of cyclosporine A pretreatment on porcine hepatic ischemia followed by
reperfusion. Surgical Forum
XLVI, 1995.
56.
Hasse
J, Blue L, Liepa G, Goldstein R, Jennings L, Mor E, Husberg B, Levy M,
Gonwa T, and Klintmalm G:
Early enteral nutrition support in patients undergoing liver
transplantation. Journal of
Parenteral and Enteral Nutrition 0148-0671/95/1906-0437,
1995.
57.
Klintmalm
GBG: Update on solid organ
transplantation.
58.
Levy
MF, Crippin JS, Abbasoglu O, Vodapally M, Goldstein RM, Husberg BS, Gonwa TA,
and Klintmalm GB: Adenovirus infection of the human intestinal allograft:
a case report. Trans Proc, 28(5):2786-2787, 1996.
59.
Brooks
BK, Levy MF,
60.
61.
Tong
MJ, Terrault NA and Klintmalm G. Hepatitis B transplantation: special
conditions. Semin Liver Dis 20 (Suppl 1):25-28, 2000.
(review)
62.
Klintmalm
GB.
International registry of liver tumors in liver transplantation. A registry
update on hepatocellular carcinoma (HCC). Zentralbl Chir 125(7): 642-6,
2000.
63.
Molmenti
EP and Klintmalm GB. Hepatocellular cancer in liver transplantation. J Hepatobiliary Pancreat Surg
8:427-434, 2001.
64.
Molmenti
EP, Ramsay M, Ramsay K, Lynch K, Tillmann Hein HA, Molmenti H, Levy M, Goldstein
RM, Ausloos K, East C, Fasola C, Jung G, Escobar J, and Klintmalm GB. Epoprostenol and nitric
oxide therapy for severe pulmonary hypertension in liver transplantation. Transplant Proc 33(102): 1332,
2001.
65.
Molmenti
EP, Casey D, Coke C, Jennings L, Brooks B, Marubashi S., Molmenti H, Goldstein
R, Levy M, Fasola C, Gonwa T, and Klintmalm GB. Correlation between intraoperative flows
and hepatic artery strictures in liver transplantation. Transplant Proc 33(1-2): 1494,
2001.
66.
Molmenti
EP, Levy MF, Molmenti H, Casey D,
FAsola CG, Hamilton WM, Jung G.
Marubashi S. Gogel BM, Goldstein RM, Gonwa TA, and Klintmalm GB. Correlation between intraoperative blood
flows and hepatic artery strictures in liver transplantation. Liver Trans. 2002 Feb; 8(2) :
160-3
67.
Molmenti
EP, Nagata D, Roden J, Squires R, Molmenti H, Casey D, Fasola C, Lopez MJ,
Winick N, McPhail W, D’Amico L, Goldstein R, Levy M, Fasola C, Andersen J, and
Klintmalm G. Incidence, management, and outcome of
posttransplant lymphoproliferative disease in pediatric liver transplant
recipients. Transplant Proc 33(1-2): 1727,
2001.
68.
Molmenti
E, Nagata D, Roden J, Squires R, Molmenti H, Casey D, Prestidge C, McPhail W,
Sanchez E, Goldstein R, Levy M, Fasola C, Andrews W, D’Amico L, Benser M, Emert
L, Andersen J, and Klintmalm G. Pediatric liver transplantation for
cystic fibrosis. Transplant Proc 33(1-2): 1738,
2001.
69.
Molmenti
EP, Nagata D, Roden J, Squires R, Molmenti H, Casey D, Fasola C, Tomlinson G,
Ratliff A, D’Amico L, Marubashi S, McCreight A, Jung GJ, Goldstein R, Levy M,
Andrews W, McPhail W, Emert L, Andersen J, and Klintmalm G. Liver transplantation for hepatoblastoma
in the pediatric population. Transplant Proc 33(1-2): 1749,
2001.
70.
Molmenti
E, Casey D, Jennings L, Molmenti H, Jung G, Marubashi S, Sanchez E, Goldstein R,
Levy M, Fasola C, Gonwa T, and Klintmalm
G. Leading causes of death in the liver transplant population compared to
the corresponding age-matched general
71.
Fasola
CG, Netto GJ,
72.
Fasola
CG, Netto GJ, Christensen LL, Molmenti EP, Sanchez EQ, Levy MF, Goldstein RM,
and Klintmalm GB. Delay of hepatitis
C recurrence in liver transplant recipients: impact of mycophenolate mofetil on
transplant recipients with severe acute rejection or with renal dysfunction. Transplant Proc 34(5): 1561-2,
2002.
73.
Klintmalm
GB.
The history of organ transplantation in the Baylor Health Care System. BUMC Proceedings 17:23-34,
2004.
BOOKS
1.
Busuttil RW and
Klintmalm GB, (eds).
2.
Klintmalm GB and Levy MF, (eds). Organ Procurement and Preservation.
Landes Bioscience, 1999.
3.
Molmenti EP and Klintmalm GB.
Atlas of Liver
4.
Busuttil RW and
Klintmalm GB, (eds).
BOOK
CHAPTERS
1.
Iwatsuki S,
Iwaki Y, Klintmalm G, Kano T,
2.
Starzl TE,
Iwatsuki S, Bahnson HB, van Thiel DH, Hardesty R, Griffith B, Shaw Jr BW,
Klintmalm GBG, and Porter KA: Cyclosporin A and steroids for liver and
heart transplantation. In: Cyclosporin A:
Proceedings of an International Conference on Cyclosporin A, 38:431-436.
D.J.G White, ed. Elsevier Biomedical Press,
3.
Iwatsuki S,
Klintmalm GBG, and Starzl TE: Liver transplantation. In: Rob &
Smith's Operative Surgery, 4th ed., Alimentary Tract
and Abdominal Wall. Part 2:508-519 Dudley H, Pories W, Carter D. (eds).
4.
Klintmalm
G: Clinical
experience in scandinavia. Immunotherapy
and Renal
5.
Detre KM, Belle
SH, Carr MA, Gavaler JS, Kelsey SF, Wei YL, Gross CR, Hiatt JR, Klintmalm
G, Payne WD, Van Thiel D, Wiesner RH, and Hoofnagle JH: "A report from the
NIDDK liver transplantation database." Clinical Transplants 1989, Chapter 14
129-141, P. Terasaki, ed. UCLA
Tissue Typing Laboratory,
6.
Goldstein RM,
Solomon H, Holman MJ, Gibbs JF, Mor E, Morris CA, Husberg BS, Gonwa TA, and
Klintmalm GB: Liver transplantation, 1990: a dallas perspective. Clinical Transplants 1990. Chapter
14123-133, P. Terasaki, ed. UCLA Tissue Typing Laboratory,
7.
8.
9.
Klintmalm
GB, Husberg BS,
and Starzl TE: "The organ transplanted patient---immunological concepts and
immunosuppression." The Handbook of
10.
Levy M,
Goldstein R, Husberg B, Gonwa T, Backman L, Abouljoud M, Mulligan D, and
Klintmalm G: Baylor update: outcome analysis in liver transplantation.
Terasaki, Cecka (eds). Clinical
Transplants 1993, pp 161-173, UCLA Tissue Typing Laboratory,
11.
Klintmalm
G: Liver
transplantation in patients with tumors. In Maddrey WC, Sorrel MF (eds).
503-527,
12.
Abouljoud MS,
and Klintmalm GBK: Tacrolimus immunoprophylaxis and rescue therapy in
liver transplantation. Lieberman R, Mukherjee A (eds). Principles of Drug Development in
13.
Klintmalm
GB and Busuttil
RW: The recipient hepatectomy and grafting.
14.
Klintmalm GB
and Busuttil RW:
Combined liver-kidney transplantation.
15.
Levy MF and Klintmalm GB: Postoperative
management: adults.
16.
Klintmalm
GB: Induction and
maintenance of immunosuppression.
17.
Eytan Mor and Klintmalm GB: Preoperative predictors
of outcome in liver transplantation: models for defining high-risk transplant
recipients.
18.
Levy MF and
Klintmalm GB: Long-term functional recovery and quality of life.
19.
Testa G and
Klintmalm GB: Cyclosporine and tacrolimus: the mainstay of
immunosuppressive therapy for solid organ transplantation. In: Keeffe EB, guest
ed. Clinics in Liver Disease: Liver
20.
Klintmalm
GB: Tacrolimus. Immunosuppression. Edited by Leo C.
Ginns, A. Benedict Cosimi, and Peter J. Morris. Blackwell Science,
21.
Testa
G and Klintmalm GB: Assessing suitability of the cadaver donor. Organ Procurement & Preservation,
Chapter 4, pp. 47-62. Edited by Goran B. Klintmalm and Marlon F. Levy. Landes
Bioscience, 1999.